Vir Biotechnology Newsroom

Express News | US FDA: Revoked Emergency Use Authorization for GSK and Vir Biotechnology's Sotrovimab as of Dec 13 - Website

Reuters12:12 ET

Vir Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Vir BiotechnologyDec 18 00:00 ET

Vir Gets FDA Breakthrough Therapy Status for Two Drugs

Seeking AlphaDec 12 17:03 ET

Express News | Vir Biotechnology Inc - Phase 3 Eclipse Program to Begin in First Half of 2025

ReutersDec 12 16:05 ET

Express News | Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA Prime Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta

ReutersDec 12 16:05 ET

Vir Biotechnology Receives FDA Breakthrough Therapy Designation and EMA PRIME Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta

Vir BiotechnologyDec 12 00:00 ET

Loss-making Vir Biotechnology (NASDAQ:VIR) Has Seen Earnings and Shareholder Returns Follow the Same Downward Trajectory Over Past -80%

Simply Wall StDec 10 07:18 ET

The small Kennedy effect: Major exodus of pharmaceutical stocks in the USA

Several weeks have passed since Trump nominated Alex Azar as Secretary of Health and Human Services, yet the trend of investors withdrawing from the medical care sector has not diminished. So far this year, the performance of the Health Care Select Sector SPDR Fund (XLV) in comparison to the S&P 500 index is approaching the lowest level in the past thirty years. Goldman Sachs believes that significant economic events may need to occur + related policies become clearer + corporate profit expectations are raised in order to attract investors back.

wallstreetcnDec 8 22:05 ET

JANX Stock Hits Record High on Prostate Cancer Study Data

Zacks Dec 4 09:35 ET

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

BenzingaDec 3 16:05 ET

AT&T Updates 2024 Outlook, Joins ZJK Industrial, Janux Therapeutics, Credo Technology Group And Other Big Stocks Moving Higher On Tuesday

BenzingaDec 3 10:44 ET

Janux Therapeutics Stock Soars 70% on Prostate Cancer Drug Trial Results -- Barrons.com

Barron'sDec 3 10:39 ET

Morgan Stanley Maintains Vir Biotechnology(VIR.US) With Hold Rating, Maintains Target Price $10

Moomoo NewsDec 3 06:33 ET · Ratings

Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket

BenzingaDec 3 05:54 ET

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), PTC Therapeutics (PTCT) and Vir Biotechnology (VIR)

TipRanksDec 3 05:50 ET · Ratings

Janux, Vir Stocks Rally on Positive Data for Janux Drug JANX007

Seeking AlphaDec 2 17:30 ET

Will Vir Biotechnology (NASDAQ:VIR) Spend Its Cash Wisely?

Yahoo FinanceDec 1 08:11 ET

Vir Biotechnology to Host Virtual Investor Event on PRO-XTEN Masked T-Cell Engager Programs

Vir BiotechnologyNov 26 00:00 ET

Vir Biotechnology to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Vir BiotechnologyNov 25 00:00 ET

Trump Nominates Marty Makary For FDA Commissioner

Barron'sNov 22 22:27 ET